Cathie Wood's Ark Invest Sells $7.4 Million Worth of BioNTech Stock
On July 7 and August 8, Cathie Wood’s Ark Genomic Revolution ETF sold over 120,000 shares of BioNTech stock for approximately $7.4 million, reducing its stake to just 307 shares by July 10. The move suggests a strategic shift as the fund reallocates capital amid underperformance in BioNTech's stock and financial challenges.
Topics: ARKG BioNTech Cathie Wood ETF activity